Elizaveta V Benevolenskaya
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Lipid metabolism and the serine, one-carbon, glycine (SOG) and methionine pathways are independently and significantly correlated with estrogen receptor–negative breast cancer (ERneg BC). Here, we propose a link between lipid metabolism and ERneg BC through phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the de novo serine pathway. We demonstrate that the metabolism of the paradigmatic medium-chain fatty acid octanoic acid leads to a metabolic shift toward the SOG and methionine pathways. PHGDH plays a role in both the forward direction, contributing to the production of S-adenosylmethionine, and the reverse direction, generating the oncometabolite 2-hydroxyglutarate, leading to epigenomic reprogramming and phenotypic plasticity. The methionine cycle is closely linked to the transsulfuration pathway. Consequently, we observe that the shift increases the antioxidant glutathione, which mitigates reactive oxygen species (ROS), enabling survival of a subset of cells that have undergone DNA damage. These metabolic changes contribute to several hallmarks of cancer.
Year:
2025
Diet-induced obesity leads to dysregulated myelopoiesis and nonresolving inflammation. Such dysregulation could involve epigenetic reprogramming, which can induce long-term changes in hematopoietic stem and progenitor cells (HSPCs). However, whether and how obesity-dysregulated HSPCs impact myelopoiesis in response to tissue injury are not fully understood. Here, we tested the hypothesis that obesity induces oxidative stress and histone H3 lysine-4 trimethylation (H3K4me3) in HSPCs, programming enhanced myelopoiesis and persistent inflammation, leading to impaired tissue recovery. Transfer of bone marrow HSPCs from high-fat diet–induced obese mice (HFD-HSPCs) to lean recipients was sufficient to drive nonresolving myelopoiesis and impaired tissue recovery from hindlimb ischemia. HFD-HSPCs exhibited increased oxidative stress that drives elevated H3K4me3 and reduced KDM5 demethylase activity. CUT&Tag (cleavage under targets and tagmentation) analysis revealed H3K4me3 enrichment at cell cycling regulating E2F targets during myeloid differentiation and Tlr4 gene promoter in HFD-HSPCs. Such enrichment is associated with increased TLR4-driven myelopoiesis in vitro, increased inflammatory myelopoiesis during hindlimb ischemia, and myeloid bias after serial transplantations in lean recipients. Knockout of KDM5A, an H3K4me3 demethylase and negative regulator of E2F activity, increased H3K4me3 in HSPCs, enhanced TLR4-driven myelopoiesis in vitro, and increased myelopoiesis in vivo. Furthermore, cyclosporine A treatment in HSPCs ex vivo reduced oxidative stress, normalized H3K4me3 levels, and mitigated enhanced myelopoiesis in HSPCs in HFD mice. Our findings suggest that oxidative stress by diet-induced obesity enhances H3K4me3 levels and increases myelopoiesis in HSPCs, leading to persistent inflammation and impaired recovery from hindlimb ischemia.
Year:
2025
Introduction: We have investigated the breast microenvironment to identify factors that promote Estrogen Receptor Negative Breast Cancer (ERneg BC) and that may be disrupted for prevention. To that end, we have identified a lipid metabolism gene signature associated with the risk of ERneg BC. To better understand lipid metabolism in the breast, we studied the effect of fatty acids (FA) on non-transformed breast epithelial cells and tissues. FA exposure alters histone methylation, affecting gene expression and increase flux through serine, one-carbon, glycine (SOG) and methionine pathways. The association of the serine pathway and ERneg BC was first observed over a decade ago. A SOG pathway gene signature is significantly correlated with ERneg status. We hypothesized that the metabolism of FA results in a metabolic shift toward the de novo serine synthesis pathway (SSP), which ultimately increases S-adenosylmethionine (SAM), altering histone methylation, profoundly changing gene expression and fostering ERneg oncogenesis. Methods: Non-transformed MCF-10A cells were used for in vitro metabolic and epigenomic analyses. Cells exposed to the medium-chain FA octanoic acid (OA) were utilized for proteomics and U13C-glucose tracing. SAM, glutathione (GSH) and 2-hydroxyglutarate (2-HG) concentrations were measured following treatment with OA ± blockade of the serine pathway. Reactive Oxygen Species (ROS)-induced redox changes were monitored live cells. Comet assay was performed to detect DNA damage. CUT&RUN was performed for H3K4me3. Human breast tissue derived microstructures were utilized for genomic analysis. Single-cell RNA-seq (scRNAseq) was performed in microstructures exposed to ± OA. Metabolic flux analyses was performed using Compass. Results: 13C flux analysis revealed that OA led to increased flux to methylation. OA significantly increased the main methyl donor SAM, the antioxidant GSH via the transsulfuration pathway and the oncometabolite 2-HG after 15 min exposure. Blocking the first and rate limiting enzyme in the SSP, PHGDH, prevented these increases. Proteomics revealed the overexpression of PHGDH following OA exposure. Upon exposure to OA, scRNAseq analysis revealed increased expression of the SSP transcription factor (TF) ATF3 and the SSP genes PHGDH and PSAT1 in epithelial and non-epithelial clusters. Upon OA the proportion of three subtypes within the epithelial compartment increased: basal BSL1, Hormone sensing HS1 and luminal progenitor LP3. Compass, an algorithm to characterize cellular metabolic states, revealed flux greatly increased through the three enzymes of the SSP: PHGDH, PSAT1 and PSPH secondary to OA exposure in BSL1, LP3 and HS1 cells. H3K4me3 CUT&RUN revealed 661 differential peaks (FDR < 0.05) comparing OA to control. Motif analysis revealed an overrepresentation of binding sites for SSP TFs ATF3/4 (p < 0.05). After 5 min OA exposure, mitochondrial and nuclear ROS increased significantly (p < 0.01), peaking at 15 min. OA exposure triggered DNA damage likely due to ROS increase in the nucleus. Compass predicted an increase in GSH metabolism and ROS detoxification in BSL1. Conclusions: Protein levels of PHGDH are elevated in 70% of ERneg BCs. This cannot be explained by gene amplification alone as PHGDH gene amplification is observed in only approximately 6% of all breast cancers. This suggests that there are mechanisms other than gene amplification that contribute to PHGDH dysregulation. One of those mechanisms may be the lipid induced metabolic shift toward the SOG and methionine pathways that we have identified. The increased SAM and 2-HG foster epigenetic phenotypic plasticity via altered histone methylation. ROS increase shortly after OA exposure and are controlled by antioxidant defenses (e.g. GSH), which favors the survival of specific cell subtypes with acquired DNA damage which likely facilitates malignant transformation. Citation Format: Mariana Bustamante Eduardo, Curtis W. McClosk
Year:
2025
The local breast environment is a valuable research focus for identifying the etiological and biological factors that contribute to the development of breast cancer. Single-cell RNA sequencing shows that the increased availability of the medium-chain fatty acid octanoic acid induces changes typical of the aged mammary gland, including downregulation of cell-cell junctions, altered extracellular matrix (ECM)-receptor interactions, and upregulation of aging markers like MDK and GDF15. Ex vivo exposure to medium-chain fatty acids compromises cell-cell junctions leading to cell dissemination. As aging is associated with an increased risk of developing breast cancer, it is crucial to identify the factors driving these age-related changes in the mammary gland to develop effective cancer prevention strategies. Given that the proportion of breast adipocytes increases with age, we propose that the remodeling of the mammary gland associated with aging is partly due to the increase in adipocytes and fatty-acid release.
Year:
2025
Introduction: A lipid metabolism gene signature is enriched in breast tissue at risk for estrogen receptor negative (ERneg) breast cancer (BC). Fatty acid (FA) exposure alters histone methylation, gene expression and increases metabolic flux through serine, one-carbon, glycine (SOG) and methionine pathways. We hypothesize that FA exposure induces a metabolic shift towards the SOG, increasing S-adenosylmethionine (SAM), altering histone methylation, gene expression, and promoting ERneg BC. Methods: Proteomics, metabolomics, Reactive Oxygen Species (ROS) measurement, comet assay and H3K4me3 CUT&RUN were performed in MCF-10A cells exposed to octanoic acid (OA). Single-cell RNA-seq (scRNAseq) was performed in breast tissue derived microstructures exposed to OA. Intracellular communication was analyzed using CellChat, and metabolic flux with Compass. Results: OA increased SAM, glutathione (GSH) and 2-hydroxyglutarate (2-HG); blocking the serine pathway (SSP) prevented these increases. ScRNAseq revealed that OA increased expression of the SSP transcription factor ATF3 and genes PHGDH and PSAT1 in epithelial and stromal compartments. Metabolic flux analysis revealed a significant increase in flux through SSP in Basal BSL1, Luminal Progenitor LP3, and Hormone Sensing HS1 cells after OA exposure. Differential proteomics reveals PHGDH overexpression and downregulation of proteins involved in extracellular matrix (ECM)-receptor interaction and focal adhesion post-OA exposure, along with significant increase in mitochondrial and nuclear ROS (p < 0.01). OA exposure also induced DNA damage, likely due to elevated nuclear ROS. OA increased GSH metabolism and ROS detoxification in BSL1. CUT&RUN identified 661 peaks significantly enriched upon OA (FDR < 0.01) in regulatory regions of OA-induced genes involved in neural pathways and BC, including MDK, NGF, and NGFR. CellChat predicted a decrease in ECM-cell interactions, a reduction in cell-cell adhesions, and an increase of secreted signaling upon OA exposure. The strongest secreted signals in OA were AREG (linked to proliferation, growth, and invasiveness), GDF15 (involved in EMT, invasion, and aging), and MDK (linked to neurogenesis, and aging). Conclusions: We demonstrate an FA-induced shift towards the SOG and methionine pathways that promotes epigenetic plasticity, regulates ROS, and supports the survival of cells with 'inappropriate' phenotypes. These accumulate DNA damage, leading to age-related changes in the mammary gland (elevated ROS, disrupted junctions, altered ECM interactions, and increased MDK/GDF15 expression), all supporting carcinogenesis. Our findings also provide a metabolic explanation for the elevation of PHGDH in 70% of ERneg BCs, despite gene amplification in only 6%, and point to preventive strategies targeting the SSP. Citation Format: Mariana Bustamante Eduardo, Gannon Cottone, Curtis McCloskey, Flavio Palma, Shiyu Liu, Maria Paula Zappia, Abul B.M.M.K. Islam, Elizaveta Benevolenskaya, Maxim Frolov, Jason Locasale, Marcelo Bonini, Rama Khokha, Navdeep Chandel, Seema A. Khan, Susan E. Clare. Metabolic shift towards the de novo serine pathway in non-transformed breast cells drives epigenetic plasticity, oxidative DNA damage, and pro-tumorigenic cChanges associated with aging [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5402.
Year:
2025
Introduction. A lipid metabolism gene signature is associated with the risk of estrogen negative breast cancer (ER-BC). In vitro, lipid exposure alters histone methylation affecting gene expression and increases flux through various metabolic reactions including those involved in serine, one-carbon, glycine (SOG) and methionine. We hypothesized that the metabolism of lipids in preference to glucose and glutamine results in a metabolic shift toward the serine pathway increasing S-adenosylmethionine (SAM) leading to histone methylation increases and changes in gene expression. Methods. MCF-10A cells exposed to octanoic acid (OA) were utilized for U13C-glucose tracing. SAM, glutathione (GSH) and 2-hydroxyglutarate (2-HG) concentrations were measured following treatment with OA ± the PHGDH inhibitor CBR-5884. ROS-induced redox changes were monitored live in cells transduced with ORP1-roGFP2 vectors. CUT&RUN was performed for H3K4me3. Expression of OA-induced genes was measured by rt-qPCR upon exposure to OA ± CBR-5884 or OA ± the histone methyltransferase (HMT) inhibitor Piribedil. Alkaline comet assay was done to detect DNA breaks. Single-cell RNA-seq (scRNAseq) was performed on tissue-derived breast microstructures exposed to ± OA. Results. Upon OA treatment, the Cancer index increased and 1C-THF was redirected to the methionine cycle increasing flux to methylation. OA significantly increased the production of SAM, GSH and 2-HG after 15 min. Blocking the first enzyme in the serine pathway, PHGDH, prevented these increases. After 5 min OA exposure, mitochondrial and nuclear ROS increased significantly (p < 0.0001), peaking at 15 min. H3K4me3 CUT&RUN revealed 661 differential peaks (FDR < 0.05) comparing OA to control. 73% of H3K4me3 OA-associated peaks were in regulatory regions of OA-induced genes (FDR < 0.01) including neural, EMT and ER- BC related genes. Motif analysis revealed an overrepresentation of binding sites for serine pathway transcriptional activators ATF3/4 (p < 0.05). Blocking PHGDH or HMT prevented OA-induced gene expression changes. Alkaline comet assay showed that OA significantly increased comet tails. scRNAseq revealed OA increased the numbers of cells within all cell clusters expressing ATF3 and PHGDH. Also observed was an increase in the percentage of basal BSL1, luminal progenitor LP3 and hormone sensing HS1 cells. Conclusions. Metabolism of OA results in a metabolic shift toward the SOG and methionine increasing the production of SAM, GSH and 2-HG which have implications for oncogenesis. The increased SAM fosters epigenetic phenotypic plasticity via altered histone methylation. The increased proportion of specific cell types likely reflects the survival of cells able to mitigate oxidative stress. Increased 2-HG may produce metabolic BRCAness by inhibiting 2-oxoglutarate-dependent dioxygenases. Citation Format: Mariana Bustamante Eduardo, Gannon Cottone, Shiyu Liu, Flavio R. Palma, Maria Paula Zappia, Abul B.M.M.K. Islam, Elizaveta V. Benevolenskaya, Maxim V. Frolov, Jason Locasale, Marcelo G. Bonini, Navdeep S. Chandel, Seema Khan, Susan Clare. Lipid exposure re-wires cellular metabolism away from glycolysis toward the serine pathway conferring oncogenic properties to non-transformed breast cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 444.
Year:
2024
Introduction. Oncogenic factors that are local/in-breast are of great interest as they may be more specifically targetable for breast cancer prevention than systemic factors. We have identified a lipid metabolism gene signature that is enriched in breast tissue at risk for estrogen negative breast cancer (ER- BC). Utilizing the medium chain fatty acid Octanoic acid (OA) to probe lipid metabolism in non-transformed breast epithelial cells, we observed increased flux through several metabolic reactions and altered histone methylation with consequent changes in gene expression (e.g. neural genes). Neuronal signaling and regulatory circuits are observed in cancer cells of multiple origins, not just ones with ontological relationships to neurons. We hypothesize that the first and rate limiting step in the de novo serine pathway, which is catalyzed by Phosphoglycerate Dehydrogenase (PHGDH) is key to these observations. In the forward direction, PHGDH participates in the serine, one-carbon, glycine (SOG) and methionine pathways that produce the methyl donor S-adenosylmethionine (SAM) and in the reverse direction produces the oncometabolite 2-Hydroxyglycerate (2-HG). Methods. Non-transformed MCF-10A cells exposed to OA were utilized for U13C-glucose tracing. SAM and 2-HG concentrations following treatment with OA ± PHGDH inhibitor were measured by liquid chromatography. CUT&RUN for H3K4me3 was performed and genes affected by OA (PMID: 28263391) were compared with OA-responsive peaks. Single cell RNA-sequencing was carried out using breast microstructures derived from reduction mammoplasty tissue exposed to vehicle or OA. Microstructures were dissociated into single cells and sequenced using the 10x Genomics platform. The digital expression matrix file containing UMIs were analyzed with Seurat. Alkaline comet assay was performed to detect DNA breaks. Results. U13C-glucose tracing in presence of OA revealed that one-carbon-THF was redirected to the methionine cycle increasing flux to methylation. Concentrations of SAM and 2-HG increased after 15- and 30-min OA exposure, respectively; PHGDH inhibitor blocked these increases. H3K4me3 CUT&RUN revealed 661 differential peaks (FDR < 0.05) comparing OA to control. 73% of H3K4me3 OA-associated peaks were in regulatory regions of OA-induced genes (FDR < 0.01), these genes are involved in neural pathways, EMT and ER- BC. Motif analysis revealed an overrepresentation of binding sites for transcription factors ATF3/4 (p < 0.05), which are regulators of the serine pathway. Single cell RNA-sequencing revealed OA not only affected the distribution of cell subpopulations but also modulated the expression of many genes within each subcluster. The percentage of luminal progenitor subcluster 3 increased upon OA from less than 1% to about 13%. Within basal subcluster 3, OA drives the expression of ATF3, along with two of the enzymes in the de novo serine pathway: PHGDH and PSAT1. Alkaline comet assay showed DNA breaks in OA- and control 2-HG- treated cells. Conclusions. Metabolism of OA in preference to glucose and glutamine results in a metabolic shift toward the serine pathway increasing the production of SAM and 2-HG, with implications for oncogenesis: 1. SAM production results in epigenetic fostered plasticity leading to reprogramming/selecting cells that express genes consistent with a neural/neural crest-like state. These co-opted neuronal regulatory mechanisms can make critical contributions to the acquired functional capabilities that drive cancer development. 2. 2-HG exposure results in appearance of DNA breaks, which are likely consequent to the inhibition of the alpha-ketoglutarate-dependent dioxygenases KDM 4A/B by 2-HG. Their catalytic activity is required for homologous recombination repair; inhibition results in metabolic “BRCAness”. Citation Format: Mariana Bustamante Eduardo, Gannon Cottone, Shiyu Liu, Maria Paula Zappia, Elizaveta V. Benevolenskaya, Abul Bashar Mir Md. Khademul
Year:
2024
Year:
2023
Year:
2023
Collaborators (13)
Sharon Glynn
Prof in Pathology
University of Galway
Peng Gao
Northwestern University Feinberg School of Medicine
Yuan Luo
Chief AI Officer and Associate Professor
Northwestern University
Maxim Frolov
University of Chicago
Curtis W. McCloskey
Assistant Professor
UPMC Hillman Cancer Center
Rama Khokha
Professor
University of Toronto
Xiaoling Xuei
Research professor
Indiana University School of Medicine
Seema Khan
Professor
Northwestern University Feinberg School of Medicine
Marcelo Bonini
Senior Member & Chair
H Lee Moffitt Cancer Center and Research Institute
Norifumi Urao
SUNY Upstate Medical University
Douglas Thomas
University of Chicago
Muthusamy Thiruppathi
Assistant Professor - Research
University of Illinois Chicago (UIC)
Maria Paula Zappia
Research Assistant Professor
University of Chicago
Make your next move.
Prepare your application
Review drafts before you send them.